Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

AMD is the leading cause of vision loss in anyone over 50 and globally in 2010 it was estimated to cost $340 billion to treat AMD. The costs are set to spiral over the next 20 years and really over burden the healthcare system unless people start to take preventative action.

18 Jan 2013

Stroke patients with PTSD less likely to adhere to treatment regimens

A new survey of stroke survivors has shown that those with post-traumatic stress disorder (PTSD) are less likely to adhere to treatment regimens that reduce the risk of an additional stroke. Researchers found that 65 percent of stroke survivors with PTSD failed to adhere to treatment, compared with 33 percent of those without PTSD.

18 Jan 2013

Miscarriage and molecular signals: an interview with Prof Brosens and Prof Quenby

Miscarriage is defined as the spontaneous loss of pregnancy before the baby reaches viability. Besides the physical trauma, miscarriage causes considerable anxiety, stress, and depression.

17 Jan 2013

Polypill could reduce CVD and stroke in Latin Americans by up to 21% at lower cost

A single combination pill could reduce cardiovascular disease and stroke in Latin Americans by up to 21 percent at a cost of about $35 per quality adjusted life year gained, according to a study led by a University of Wisconsin School of Medicine and Public Health research team.

17 Jan 2013

Presence of trees can improve human health

Evidence is increasing from multiple scientific fields that exposure to the natural environment can improve human health. In a new study by the U.S. Forest Service, the presence of trees was associated with human health.

17 Jan 2013

Eating diets high in sugar and fat may not affect health outcomes of older adults

Eating diets high in sugar and fat may not affect the health outcomes of older adults ages 75 and up, suggesting that placing people of such advanced age on overly restrictive diets to treat their excess weight or other conditions may have little benefit, according to researchers at Penn State and Geisinger Healthcare System.

16 Jan 2013

SLU researchers examine health outcomes for obese transplant recipients

In a research review article published in the American Journal of Nephrology, Saint Louis University investigators examined data from multiple studies to better understand how obesity, an epidemic in the U.S., impacts kidney transplant patients.

16 Jan 2013

Spacemen upset sodium balance theories

Levels of salt in the body and sodium in the urine fluctuate over fixed cycles that are independent of salt intake, shows a space simulation study.

15 Jan 2013

Research scrambles previous findings on health impact of eggs

Increased egg consumption is not associated with a higher risk for coronary heart disease or stroke in the general population, research suggests.

14 Jan 2013

Baboon embryonic stem cells can be programmed to completely restore severely damaged arteries

Scientists at the Texas Biomedical Research Institute have for the first time demonstrated that baboon embryonic stem cells can be programmed to completely restore a severely damaged artery. These early results show promise for eventually developing stem cell therapies to restore human tissues or organs damaged by age or disease.

11 Jan 2013

New York State WIC program reduces rates of obesity among children

New York children participating in a federal nutrition program had healthier eating behaviors and lower rates of obesity two years after improvements to the program were undertaken, according to a study published online today in Obesity, the official journal of the Obesity Society.

10 Jan 2013

Nutrisystem reduces arterial stiffness associated with menopause and obesity

Arturo Figueroa, a researcher in the Florida State University College of Human Sciences, has confirmed with a team of researchers that Nutrisystem, with or without low intense resistance exercise, improves arterial function in obese, postmenopausal women.

9 Jan 2013

Brown University receives Irene Diamond Fund gift to launch major initiative on healthy aging

Brown University's Program in Public Health has received a gift from the Irene Diamond Fund to launch a major initiative on healthy aging.

9 Jan 2013

People from low socio-economic positions in Britain eat more salt than the well off

People from low socio-economic positions in Britain eat more salt than the well off, irrespective of where they live, states a paper led by Warwick Medical School published on Tuesday in the BMJ Open journal .

9 Jan 2013

Fertility window research uncovers miscarriage mechanism

Research in animals has shed light on how recurrent miscarriage is related to a dysregulation of the monthly “fertility window.”

8 Jan 2013

Arterial elasticity link to lung function

People with reduced arterial elasticity may have impaired lung function, and vice versa, say US researchers.

8 Jan 2013

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.

8 Jan 2013

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced positive, statistically significant data from the Company's Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb (also referred to as SPI-014) in healthy volunteers.

8 Jan 2013

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA’s review to be completed in the first half of 2013.

7 Jan 2013

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.

7 Jan 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

Stroke patients with PTSD less likely to adhere to treatment regimens

Miscarriage and molecular signals: an interview with Prof Brosens and Prof Quenby

Polypill could reduce CVD and stroke in Latin Americans by up to 21% at lower cost

Presence of trees can improve human health

Eating diets high in sugar and fat may not affect health outcomes of older adults

SLU researchers examine health outcomes for obese transplant recipients

Spacemen upset sodium balance theories

Research scrambles previous findings on health impact of eggs

Baboon embryonic stem cells can be programmed to completely restore severely damaged arteries

New York State WIC program reduces rates of obesity among children

Nutrisystem reduces arterial stiffness associated with menopause and obesity

Brown University receives Irene Diamond Fund gift to launch major initiative on healthy aging

People from low socio-economic positions in Britain eat more salt than the well off

Fertility window research uncovers miscarriage mechanism

Arterial elasticity link to lung function

Esperion reports positive results from ETC-1002 Phase 2 clinical trial on type 2 diabetes

Spectrum Pharmaceuticals reveals positive RenaZorb Phase 1 clinical trial results

Merck’s resubmission of the NDA for suggammadex sodium injection accepted for review by the FDA

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in